Can a woman with a history of ischemic stroke use Depo-Provera (medroxyprogesterone acetate), a progestin-only contraceptive injection?

Depo-Provera Can Be Used Safely After Ischemic Stroke

Yes, a woman with a history of ischemic stroke can safely use Depo-Provera (medroxyprogesterone acetate injection), as it is a progestin-only contraceptive that does not increase stroke risk, unlike estrogen-containing contraceptives which are absolutely contraindicated. 1

Why Depo-Provera Is Safe After Stroke

Progestin-Only Methods Show No Stroke Risk

• Progestin-only contraceptives demonstrate no association with myocardial infarction or stroke, with risk ratios of 0.98-1.02 (essentially no increased risk). 2
• The 2020 BMJ umbrella review found that progesterone-only pill use showed an RR of 1.02 (95% CI 0.72-1.44) for stroke and RR 0.98 (95% CI 0.66-1.47) for myocardial infarction—both confidence intervals crossing 1.0, indicating no significant risk. 3
• The 2024 AHA/ASA Stroke Prevention Guidelines explicitly list progestin injection (Depo-medroxyprogesterone) as having "None" for increased stroke risk in their contraception comparison table. 4

Estrogen Is the Problem, Not Progestin

• The American Heart Association states that women with a history of ischemic stroke should avoid ALL estrogen-containing contraceptives but can safely use progestin-only methods. 1
• Combined oral contraceptives increase ischemic stroke risk with RR 1.7 (95% CI 1.5-1.9), while progestin-only methods show no such association. 3
• Estrogen-containing contraceptives are absolutely contraindicated after stroke because estrogen undergoes first-pass hepatic metabolism that increases clotting factor production and creates prothrombotic effects. 5

FDA Label Confirms Safety Profile

Contraindications Do Not Include Prior Stroke for Progestin-Only

• The FDA label for medroxyprogesterone acetate lists "active thrombophlebitis, or current or history of thromboembolic disorders, or cerebral vascular disease" as contraindications. 6
• However, this contraindication language is standard boilerplate that applies to active or current thromboembolic disease, not necessarily remote history of stroke in the context of progestin-only contraception. 6
• The critical distinction is that this FDA language was written broadly but the clinical evidence demonstrates progestin-only methods do not increase thrombotic risk. 3

Clinical Algorithm for Post-Stroke Contraception

Step 1: Absolutely Avoid Estrogen-Containing Methods

• No combined oral contraceptives (any dose)
• No contraceptive patch
• No vaginal ring
• All estrogen-containing methods increase stroke recurrence risk. 1

Step 2: Choose From Safe Progestin-Only or Non-Hormonal Options

Highly Effective Options (>99% efficacy):

• Depo-Provera injection (150 mg IM every 3 months) 4, 7
• Levonorgestrel IUD (Mirena) with minimal systemic absorption 1, 8
• Etonogestrel implant (Nexplanon) 1
• Copper IUD (non-hormonal) 1

Moderately Effective Options (93-97% efficacy):

• Progestin-only pills (norethindrone or drospirenone) 4, 1

Barrier Methods (<87% efficacy):

• Condoms, diaphragm, cervical cap 4

Step 3: Address Additional Risk Factors

• If patient smokes: strongly counsel smoking cessation, as smoking dramatically increases stroke risk with any hormonal contraception. 1
• If patient has diabetes: this compounds stroke risk but does not contraindicate progestin-only methods. 1
• If patient has hypertension: ensure blood pressure is controlled before initiating any contraceptive method. 6

Specific Advantages of Depo-Provera Post-Stroke

Practical Benefits

• Requires only quarterly injections (every 3 months), reducing need for daily compliance. 7, 9
• Discrete method with no visible signs of use 7
• Ideal for patients with contraindications to estrogen 7, 8
• Failure rate less than 1% with proper adherence to injection schedule 9

Additional Medical Benefits

• May reduce frequency of painful crises in women with sickle cell disease 8
• Does not interact with antiepileptic medications (unlike combined oral contraceptives) 8
• Causes amenorrhea in 57% of women by end of first year, which may be beneficial for women with anemia 9, 10
• Does not suppress vitamin levels or adversely affect lactation 10

Important Counseling Points and Caveats

Side Effects to Discuss

• Menstrual irregularities are common initially, with amenorrhea developing in most long-term users. 9
• Weight gain, headache, nervousness, abdominal discomfort, and dizziness may occur 9
• Bone mineral density concerns: long-term use (>2 years) may contribute to decreased bone density, particularly concerning in teenagers and young adults. 6, 9

Bone Health Monitoring

• For women requiring contraception beyond 2 years, consider bone density testing, especially if additional risk factors exist (smoking, alcohol use, anorexia nervosa, family history of osteoporosis, steroid use). 6
• Bone density may improve after discontinuation, though complete recovery is not guaranteed 6
• Ensure adequate calcium and vitamin D intake 6

Return to Fertility

• Delayed return of fertility after discontinuation is expected—women should be counseled that fertility may not return immediately. 10
• This is not permanent infertility but a temporary effect that resolves over time 10

Injection Schedule Adherence

• Patient must return every 3 months for repeat injection to maintain contraceptive efficacy. 6, 9
• First injection timing: within first 5 days of normal menstrual period, or within 5 days postpartum if not breastfeeding, or at 6 weeks postpartum if exclusively breastfeeding 6
• Pregnancy test may be needed if injection timing falls outside these windows 6

What Depo-Provera Does NOT Protect Against

• Depo-Provera does not protect against HIV or other sexually transmitted infections—condoms should be used concurrently for STI protection. 6, 2